le areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
Highlights from the ratings report include:
◾ The revenue growth came in higher than the industry average of 2.3%. Since the same quarter one year prior, revenues slightly increased by 9.8%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
◾ APT has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 12.72, which clearly demonstrates the ability to cover short-term cash needs.
◾ Powered by its strong earnings growth of 150.00% and other important driving factors, this stock has surged by 343.50% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, although almost any stock can fall in a broad market decline, APT should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
◾ ALPHA PRO TECH LTD reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. During the past fiscal year, ALPHA PRO TECH LTD increased its bottom line by earning $0.11 versus $0.05 in the prior year.
◾ The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Building Products industry. The net income increased by 88.4% when compared to the same quarter one year prior, rising from $0.48 million to $0.90 million
Let me guess, kip ... since you pump so many different stocks, I'll take a WAG and say it's IBIO?
Sold off on half of yesterday's volume AND the overall market weakening due to oil and Canada situation. Not happy where it ended up, but all things considered, not unexpected. We are still in the process of decoupling from LAKE, IMO. APT is a stronger company fundamentally and does stand to garner business due to new guidelines for equipment. There's NO way that this business does not fall to bottom line which wa already improving year over year. The market, caught up in buy this Ebola stock and sell that Ebola stock, may just be underestimating APT.
I figure the downside is much less risk than the potential upside, so I'm accumulating. Do your own DD.
With all due respect ... again, WHY do you feel the need to stick your finger in the eye of this board? Congrats on your recent gains in MDXG. I suspect there is plenty of room for two providers! Grow up!
Now, with the market weakening due to Canada situation, they took control. This move will likely take us down to the $3.25 area?
Yes, I saw that! And, now LAKE broke support, as I suspect, we will follow due to the situation up in the Canadian Parliament ... shooting and our embassy on lockdown!
I plan to buy some on the dip!
We're getting a little "event" today with the shooting in Canada and our embassy under lockdown up there. The market is selling off. Watch what OSIR does ... I suspect, NOTHING!
$13.85ish bottom for LAKE gets tested time and time again. We're at about $4.50 level (except when they run stops like the open).
I'd rather be in APT because they are a fundamentally stronger company ... I'm thinking there's some serious accumulation going on in this area ...
Why would I lie about it. In fact, I backed the DVR up to listen again to make sure I heard it right! Just thought it was funny and am always happy when Cramer isn't "on to" a stock I'm in.
Have a good day!
Notice how "they" must be a little fearful, though, as end of day seems to find its way back up to unchanged? Hate to jinx it, but that's been the pattern, of late!
Hope we break out of this pattern soon ... tick tock!
Thanks, spaghetti ... You are absolutely right, I just meant market perception might misinterpret that sentence in the release that states they haven 't been chosen, yet. Of course, they will be.
Supposedly clear of Ebola symptoms, but are being watched. They came from Liberia, traveling separately, both vomited, etc. So how do they know for sure they don't have it?
But, they said they are symptom free of Ebola. How can they know, for sure? They were traveling separately from Liberia. Time will tell?
TKMR just announced a/h that they've got their treatment available now, too.
I tried to post the article immediately as I saw the spike a/h. Now, be careful because the pr also states that while they have the medicine ready, they have not, yet, been selected. NLNK also is in human trials and will have the dozing results by Dec. I own both, so I'm not saying there won't be room for more than one company's treatment, as there should be!